EMEA-000671-PIP01-09-M10
Key facts
| Invented name |
Revatio
|
| Active substance |
sildenafil
|
| Therapeutic area |
Other
|
| Decision number |
P/0016/2019
|
| PIP number |
EMEA-000671-PIP01-09-M10
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of pulmonary arterial hypertension
|
| Route(s) of administration |
|
| Contact for public enquiries |
Pfizer Europe MA EEIG
Tel. +44 (0)1304 646 607 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000671-PIP01-09-M10
|
| Compliance opinion date |
20/09/2019
|
| Compliance outcome |
positive
|